10.15

2.51% 0.17

Gh Research Plc (GHRS)

Überblick Nachrichten Preisverlauf Optionskette Forum Prognose

Schlusskurs vom Vortag:

$9.98

Offen:

$10.06

24-Stunden-Volumen:

11,641

Relative Volume:

0.05

Marktkapitalisierung:

$637.03M

Einnahmen:

Nettoeinkommen (Verlust:

$-41.43M

KGV:

-12.85

EPS:

-0.79

Netto-Cashflow:

$-39.97M

1W Leistung:

-5.28%

1M Leistung:

+13.79%

6M Leistung:

+12.54%

1J Leistung:

-19.70%

1-Tages-Spanne:

$9.52

$10.28

1-Wochen-Bereich:

$9.4557

$11.22

52-Wochen-Spanne:

$6.00

$20.50

Gh Research Plc Stock (GHRS) Company Profile

Firmenname

Gh Research Plc

Sektor

Healthcare (1158)

Branche

Biotechnology (673)

Telefon

Adresse

Mitarbeiter

Twitter

Nächster Verdiensttermin

Neueste SEC-Einreichungen

GHRS's Discussions on Twitter

Vergleichen Sie GHRS mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
GHRS Gh Research Plc	10.14	637.03M	0	-41.43M	-39.97M	-0.79
VRTX Vertex Pharmaceuticals Inc	432.76	111.66B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	574.44	60.56B	14.09B	4.50B	2.96B	39.28
ARGX Argen X Se Adr	546.50	38.04B	2.58B	1.06B	-1.28B	16.33
ALNY Alnylam Pharmaceuticals Inc	278.12	36.06B	2.35B	-269.70M	-75.39M	-2.09
ONC Beigene Ltd Adr	224.39	25.10B	3.81B	-644.79M	-669.77M	-6.24

Gh Research Plc Stock (GHRS) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-03-13	Eingeleitet	Guggenheim	Buy
2025-03-07	Eingeleitet	RBC Capital Mkts	Outperform
2025-02-13	Eingeleitet	Cantor Fitzgerald	Overweight
2022-08-16	Eingeleitet	H.C. Wainwright	Buy
2022-06-16	Eingeleitet	ROTH Capital	Buy

Gh Research Plc Aktie (GHRS) Neueste Nachrichten

07:32 AM

GH Research Showcases Promising Depression Treatment Data at ASCP Meeting - TipRanks

07:32 AM

07:00 AM

GH Research Announces Acceptance of Pharmaceutical Pipeline Presentation and Late-Breaking Posters at the American Society of Clinical Psychopharmacology 2025 Annual Meeting - TradingView

07:00 AM

May 12, 2025

GH Research’s (GHRS) “Buy” Rating Reiterated at HC Wainwright - Defense World

May 12, 2025

Guggenheim Cuts GH Research (NASDAQ:GHRS) Price Target to $29.00 - Defense World

May 12, 2025

May 10, 2025

GH Research (GHRS) Price Target Lowered by Guggenheim | GHRS Sto - GuruFocus

May 10, 2025

GHRS Stock: HC Wainwright & Co. Reiterates Buy Rating | GHRS Sto - GuruFocus

May 10, 2025

May 08, 2025

GH Research PLC Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 08, 2025

GHRS Reports Strong Financial Position with Increased Cash Holdi - GuruFocus

May 08, 2025

GH Research Reports Q1 2025 Financial Results Amidst Ongoing Challenges - TipRanks

May 08, 2025

GH Research PLC Reports Positive Phase 2b Trial Results for GH001 in Treatment-Resistant Depression and Financial Update for Q1 2025 - Nasdaq

May 08, 2025

GH Research Reports First Quarter 2025 Financial Results and Provides Business Updates - Stock Titan

May 08, 2025

May 05, 2025

What Makes GH Research (GHRS) a New Buy Stock - Yahoo Finance

May 05, 2025

May 01, 2025

Where are the Opportunities in (GHRS) - news.stocktradersdaily.com

May 01, 2025

Hims & Hers Health (NYSE:HIMS) Shares Down 8.3% Following Insider Selling - American Banking and Market News

May 01, 2025

Apr 21, 2025

Legal & General Group Plc Sells 18,302 Shares of Guardant Health, Inc. (NASDAQ:GH) - Defense World

Apr 21, 2025

Apr 18, 2025

What Will GH Research PLC (NASDAQ: GHRS) Be Like In 2025 - Stocksregister

Apr 18, 2025

Apr 16, 2025

Psyence BioMed invests half a million into natural psychedelics operator PsyLabs - Mugglehead Magazine

Apr 16, 2025

JOYY, Akebia Therapeutics, Microchip Technology And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga

Mar 20, 2025

Mar 13, 2025

Guggenheim starts GH Research at Buy, sees long-term upside potential - Yahoo Finance

Mar 13, 2025

Guggenheim Initiates Coverage of GH Research (GHRS) with Buy Recommendation - Nasdaq

Mar 13, 2025

Mar 11, 2025